id
stringlengths 11
11
| tags
stringlengths 10
777
| text
stringlengths 2
1.5k
| dataset_num
int64 1
3
| tokens
list | ner_tags
list |
|---|---|---|---|---|---|
NCT02425904
|
27:39:treatment,43:55:treatment,,84:96:treatment,100:111:treatment,247:271:treatment
|
Participants who have had chemotherapy or radiotherapy within 2 weeks (6 weeks for nitrosoureas or mitomycin C) prior to entering the study or those who have not recovered from adverse events due to agents administered more than 2 weeks earlier. Corticosteroid treatment is allowed
| 1
|
[
"Participants",
"who",
"have",
"had",
"chemotherapy",
"or",
"radiotherapy",
"within",
"2",
"weeks",
"(",
"6",
"weeks",
"for",
"nitrosoureas",
"or",
"mitomycin",
"C",
")",
"prior",
"to",
"entering",
"the",
"study",
"or",
"those",
"who",
"have",
"not",
"recovered",
"from",
"adverse",
"events",
"due",
"to",
"agents",
"administered",
"more",
"than",
"2",
"weeks",
"earlier",
".",
"Corticosteroid",
"treatment",
"is",
"allowed"
] |
[
0,
0,
0,
0,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0
] |
NCT02092324
|
32:61:allergy_name
|
Previous allergic reactions to janus kinase (JAK) inhibitors or excipients
| 1
|
[
"Previous",
"allergic",
"reactions",
"to",
"janus",
"kinase",
"(",
"JAK",
")",
"inhibitors",
"or",
"excipients"
] |
[
0,
0,
0,
0,
4,
4,
4,
4,
0,
0,
0,
0
] |
NCT01415882
|
20:40:treatment,58:68:treatment,73:84:treatment,,125:132:treatment,,
|
Patients should be proteasome inhibitor naïve (including bortezomib and carfilzomib) OR have received less than 6 cycles of therapy with a bortezomib or carfilzomib containing regimen and were not refractory to the bortezomib or carfilzomib based regimen (less than a PR or progression on or within 60 days of discontinuation)
| 1
|
[
"Patients",
"should",
"be",
"proteasome",
"inhibitor",
"naïve",
"(",
"including",
"bortezomib",
"and",
"carfilzomib",
")",
"OR",
"have",
"received",
"less",
"than",
"6",
"cycles",
"of",
"therapy",
"with",
"a",
"bortezomib",
"or",
"carfilzomib",
"containing",
"regimen",
"and",
"were",
"not",
"refractory",
"to",
"the",
"bortezomib",
"or",
"carfilzomib",
"based",
"regimen",
"(",
"less",
"than",
"a",
"PR",
"or",
"progression",
"on",
"or",
"within",
"60",
"days",
"of",
"discontinuation",
")"
] |
[
0,
0,
0,
1,
1,
0,
0,
0,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01851694
|
13:28:treatment,
|
intravenous corticosteroids within 6 weeks of study
| 1
|
[
"intravenous",
"corticosteroids",
"within",
"6",
"weeks",
"of",
"study"
] |
[
0,
1,
0,
0,
0,
0,
0
] |
NCT02561988
|
1:17:cancer
|
Brain malignancy
| 1
|
[
"Brain",
"malignancy"
] |
[
3,
3
] |
NCT01891318
|
1:9:cancer
|
lymphoma
| 1
|
[
"lymphoma"
] |
[
3
] |
NCT03065907
|
22:66:chronic_disease,
|
Primary diagnosis of neovascular age-related macular degeneration in the index eye or in both eyes if habitual visual acuity (HVA) is equivalent in both eyes
| 1
|
[
"Primary",
"diagnosis",
"of",
"neovascular",
"age-related",
"macular",
"degeneration",
"in",
"the",
"index",
"eye",
"or",
"in",
"both",
"eyes",
"if",
"habitual",
"visual",
"acuity",
"(",
"HVA",
")",
"is",
"equivalent",
"in",
"both",
"eyes"
] |
[
0,
0,
0,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02496585
|
16:46:chronic_disease
|
Active chronic Hepatitis C and/or B infection
| 1
|
[
"Active",
"chronic",
"Hepatitis",
"C",
"and/or",
"B",
"infection"
] |
[
0,
0,
2,
2,
2,
2,
2
] |
NCT01760863
|
27:75:treatment,187:210:treatment,246:262:treatment
|
Adult patients undergoing 2-stage revision arthroplasty of the knee or hip with the causative organism(s) identified using tissue culture and/or joint fluid analysis that is amenable to oral antibiotic therapy. Patients must be able to tolerate oral antibiotics and agree to participate in the study
| 1
|
[
"Adult",
"patients",
"undergoing",
"2-stage",
"revision",
"arthroplasty",
"of",
"the",
"knee",
"or",
"hip",
"with",
"the",
"causative",
"organism",
"(",
"s",
")",
"identified",
"using",
"tissue",
"culture",
"and/or",
"joint",
"fluid",
"analysis",
"that",
"is",
"amenable",
"to",
"oral",
"antibiotic",
"therapy",
".",
"Patients",
"must",
"be",
"able",
"to",
"tolerate",
"oral",
"antibiotics",
"and",
"agree",
"to",
"participate",
"in",
"the",
"study"
] |
[
0,
0,
0,
1,
1,
1,
1,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02667418
|
,,,,74:92:treatment
|
Negative pregnancy test required for females <61 years of age or without prior hysterectomy
| 1
|
[
"Negative",
"pregnancy",
"test",
"required",
"for",
"females",
"<",
"61",
"years",
"of",
"age",
"or",
"without",
"prior",
"hysterectomy"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02004275
|
4:25:treatment,
|
No platelet transfusions within 7 days of registration to meet eligibility criteria
| 1
|
[
"No",
"platelet",
"transfusions",
"within",
"7",
"days",
"of",
"registration",
"to",
"meet",
"eligibility",
"criteria"
] |
[
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02471430
|
10:13:chronic_disease
|
negative HCV PCR if anti-HCV antibodies are positive
| 1
|
[
"negative",
"HCV",
"PCR",
"if",
"anti-HCV",
"antibodies",
"are",
"positive"
] |
[
0,
2,
0,
0,
0,
0,
0,
0
] |
NCT01793519
|
43:58:treatment,
|
Treated with intramuscular or intravenous corticosteroids in the last 6 months for RA activity
| 1
|
[
"Treated",
"with",
"intramuscular",
"or",
"intravenous",
"corticosteroids",
"in",
"the",
"last",
"6",
"months",
"for",
"RA",
"activity"
] |
[
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02301663
|
1:18:treatment
|
metallic implants
| 1
|
[
"metallic",
"implants"
] |
[
1,
1
] |
NCT02908906
|
45:57:cancer
|
Participants enrolled into Part 2 must have tumor tissue available for correlative studies
| 1
|
[
"Participants",
"enrolled",
"into",
"Part",
"2",
"must",
"have",
"tumor",
"tissue",
"available",
"for",
"correlative",
"studies"
] |
[
0,
0,
0,
0,
0,
0,
0,
3,
3,
0,
0,
0,
0
] |
NCT02774421
|
1:13:cancer
|
mixed glioma
| 1
|
[
"mixed",
"glioma"
] |
[
3,
3
] |
NCT02072148
|
1:4:chronic_disease,14:19:cancer,51:54:treatment
|
HPV negative OPSCC as determined by determined by PCR
| 1
|
[
"HPV",
"negative",
"OPSCC",
"as",
"determined",
"by",
"determined",
"by",
"PCR"
] |
[
2,
0,
3,
0,
0,
0,
0,
0,
1
] |
NCT02162420
|
1:21:cancer,,,,
|
Refractory cytopenia defined by bone marrow cellularity <50% (with < 30% residual hematopoietic cells)
| 1
|
[
"Refractory",
"cytopenia",
"defined",
"by",
"bone",
"marrow",
"cellularity",
"<",
"50",
"%",
"(",
"with",
"<",
"30",
"%",
"residual",
"hematopoietic",
"cells",
")"
] |
[
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02430077
|
1:24:chronic_disease
|
Acute medical illnesses precluding participation in the studies
| 1
|
[
"Acute",
"medical",
"illnesses",
"precluding",
"participation",
"in",
"the",
"studies"
] |
[
2,
2,
2,
0,
0,
0,
0,
0
] |
NCT02385110
|
73:76:chronic_disease
|
The diagnostic criteria that have been traditionally used for children (HLH 1991 and HLH 2004) may not adequately diagnose HLH in adults
| 1
|
[
"The",
"diagnostic",
"criteria",
"that",
"have",
"been",
"traditionally",
"used",
"for",
"children",
"(",
"HLH",
"1991",
"and",
"HLH",
"2004",
")",
"may",
"not",
"adequately",
"diagnose",
"HLH",
"in",
"adults"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02495168
|
,,,,90:99:treatment,109:119:treatment,121:138:treatment
|
≥15% and ≥ 0.20 L reversibility of FEV1 within 30 minutes following 360 mcg (4 puffs) of albuterol (400 mcg salbutamol) inhalation (pMDI)
| 1
|
[
"≥15",
"%",
"and",
"≥",
"0.20",
"L",
"reversibility",
"of",
"FEV1",
"within",
"30",
"minutes",
"following",
"360",
"mcg",
"(",
"4",
"puffs",
")",
"of",
"albuterol",
"(",
"400",
"mcg",
"salbutamol",
")",
"inhalation",
"(",
"pMDI",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
1,
0,
1,
1,
0,
0
] |
NCT02674529
|
55:67:treatment
|
Have a history of inadequate response/tolerability to escitalopram
| 1
|
[
"Have",
"a",
"history",
"of",
"inadequate",
"response/tolerability",
"to",
"escitalopram"
] |
[
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT01542879
|
1:14:chronic_disease,15:30:chronic_disease,85:96:treatment
|
Hemosiderosis/hemochromatosis (patients can still be included in 2nd branch without ferumoxytol)
| 1
|
[
"Hemosiderosis/hemochromatosis",
"(",
"patients",
"can",
"still",
"be",
"included",
"in",
"2nd",
"branch",
"without",
"ferumoxytol",
")"
] |
[
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0
] |
NCT02004275
|
18:25:cancer,
|
Marrow burden of myeloma of at least 30%
| 1
|
[
"Marrow",
"burden",
"of",
"myeloma",
"of",
"at",
"least",
"30",
"%"
] |
[
0,
0,
0,
3,
0,
0,
0,
0,
0
] |
NCT02053792
|
1:21:chronic_disease
|
vitamin K deficiency of the newborn
| 1
|
[
"vitamin",
"K",
"deficiency",
"of",
"the",
"newborn"
] |
[
2,
2,
2,
0,
0,
0
] |
NCT01293214
|
24:34:cancer
|
High risk of return of malignancy
| 1
|
[
"High",
"risk",
"of",
"return",
"of",
"malignancy"
] |
[
0,
0,
0,
0,
0,
3
] |
NCT02393794
|
56:65:treatment
|
who have not fully recovered from side effects of such treatment
| 1
|
[
"who",
"have",
"not",
"fully",
"recovered",
"from",
"side",
"effects",
"of",
"such",
"treatment"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT01959698
|
,,142:171:treatment,179:197:treatment,206:219:treatment
|
Measurable or assessable disease is required; measurable tumor size (at least one node measuring 2.25 cm^2 in bidimensional measurement) per computed tomography (CT) scan, other radiological study, and/or physical exam
| 1
|
[
"Measurable",
"or",
"assessable",
"disease",
"is",
"required",
";",
"measurable",
"tumor",
"size",
"(",
"at",
"least",
"one",
"node",
"measuring",
"2.25",
"cm^2",
"in",
"bidimensional",
"measurement",
")",
"per",
"computed",
"tomography",
"(",
"CT",
")",
"scan",
",",
"other",
"radiological",
"study",
",",
"and/or",
"physical",
"exam"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
0,
0,
0,
0,
1,
1,
0,
0,
1,
1
] |
NCT02265874
|
,60:70:treatment,125:143:treatment,145:157:treatment,159:171:treatment,173:184:treatment,
|
Patients must have been treated with at least 10 mg/day of prednisone or equivalent or one or more immunomodulating agents (hydroxychloroquine, methotrexate, azathioprine, leflunomide) for >3 months before screening
| 1
|
[
"Patients",
"must",
"have",
"been",
"treated",
"with",
"at",
"least",
"10",
"mg/day",
"of",
"prednisone",
"or",
"equivalent",
"or",
"one",
"or",
"more",
"immunomodulating",
"agents",
"(",
"hydroxychloroquine",
",",
"methotrexate",
",",
"azathioprine",
",",
"leflunomide",
")",
"for",
">",
"3",
"months",
"before",
"screening"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT02316574
|
29:38:treatment
|
Legally mandated to receive treatment
| 1
|
[
"Legally",
"mandated",
"to",
"receive",
"treatment"
] |
[
0,
0,
0,
0,
1
] |
NCT02578732
|
13:23:chronic_disease
|
Preexisting neuropathy is not allowed from any cause
| 1
|
[
"Preexisting",
"neuropathy",
"is",
"not",
"allowed",
"from",
"any",
"cause"
] |
[
0,
2,
0,
0,
0,
0,
0,
0
] |
NCT02252432
|
10:21:treatment
|
Emergent laminectomy
| 1
|
[
"Emergent",
"laminectomy"
] |
[
0,
1
] |
NCT02501473
|
18:24:cancer,,48:83:cancer,88:114:cancer
|
History of other cancer within 2 years (except non-melanoma cutaneous malignancies and cervical carcinoma in situ)
| 1
|
[
"History",
"of",
"other",
"cancer",
"within",
"2",
"years",
"(",
"except",
"non-melanoma",
"cutaneous",
"malignancies",
"and",
"cervical",
"carcinoma",
"in",
"situ",
")"
] |
[
0,
0,
0,
3,
0,
0,
0,
0,
0,
3,
3,
3,
0,
3,
3,
3,
3,
0
] |
NCT01627301
|
1:9:chronic_disease
|
diabetes
| 1
|
[
"diabetes"
] |
[
2
] |
NCT02446457
|
,,,,,,143:152:treatment
|
Serum total bilirubin =< 1.5 x ULN OR direct bilirubin =< ULN for subjects with total bilirubin levels > 1.5 ULN, performed within 28 days of treatment initiation
| 1
|
[
"Serum",
"total",
"bilirubin",
"=",
"<",
"1.5",
"x",
"ULN",
"OR",
"direct",
"bilirubin",
"=",
"<",
"ULN",
"for",
"subjects",
"with",
"total",
"bilirubin",
"levels",
">",
"1.5",
"ULN",
",",
"performed",
"within",
"28",
"days",
"of",
"treatment",
"initiation"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0
] |
NCT02159495
|
22:40:treatment,42:55:treatment,59:68:treatment,
|
His/her last dose of prior chemotherapy, immunotherapy or radiation is at least 2 weeks out from PBMC collection
| 1
|
[
"His/her",
"last",
"dose",
"of",
"prior",
"chemotherapy",
",",
"immunotherapy",
"or",
"radiation",
"is",
"at",
"least",
"2",
"weeks",
"out",
"from",
"PBMC",
"collection"
] |
[
0,
0,
0,
0,
1,
1,
0,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02964741
|
34:52:chronic_disease,59:72:chronic_disease,94:101:chronic_disease,105:128:chronic_disease,,
|
History or current evidence of a psychotic disorder (e.g. schizophrenia) or substance abuse; bipolar or severe major depression, as evidenced by Beck Depression score of ≥ 30
| 1
|
[
"History",
"or",
"current",
"evidence",
"of",
"a",
"psychotic",
"disorder",
"(",
"e.g",
".",
"schizophrenia",
")",
"or",
"substance",
"abuse",
";",
"bipolar",
"or",
"severe",
"major",
"depression",
",",
"as",
"evidenced",
"by",
"Beck",
"Depression",
"score",
"of",
"≥",
"30"
] |
[
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
2,
0,
0,
0,
0,
0,
2,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01986075
|
1:26:chronic_disease
|
Coronary vascular disease
| 1
|
[
"Coronary",
"vascular",
"disease"
] |
[
2,
2,
2
] |
NCT02271711
|
9:23:treatment
|
Chronic corticosteroid dependence
| 1
|
[
"Chronic",
"corticosteroid",
"dependence"
] |
[
0,
1,
0
] |
NCT00909909
|
1:20:cancer
|
Medullary carcinoma
| 1
|
[
"Medullary",
"carcinoma"
] |
[
3,
3
] |
NCT02584647
|
10:33:chronic_disease,35:61:chronic_disease,,128:146:chronic_disease
|
unstable coronary artery disease (myocardial infarction (MI) more than 6 months prior to study entry is permitted); or serious cardiac arrhythmia
| 1
|
[
"unstable",
"coronary",
"artery",
"disease",
"(",
"myocardial",
"infarction",
"(",
"MI",
")",
"more",
"than",
"6",
"months",
"prior",
"to",
"study",
"entry",
"is",
"permitted",
")",
";",
"or",
"serious",
"cardiac",
"arrhythmia"
] |
[
0,
2,
2,
2,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2
] |
NCT02286687
|
,36:45:treatment,36:152:treatment,112:120:treatment,122:132:treatment,137:152:treatment,
|
Patients must be >= 4 weeks beyond treatment with any chemotherapy or other investigational therapy to include hormonal, biological, or targeted agents; or at least 5 half-lives from hormonal, biological, or targeted agents, whichever is shorter at the time of treatment initiation
| 1
|
[
"Patients",
"must",
"be",
">",
"=",
"4",
"weeks",
"beyond",
"treatment",
"with",
"any",
"chemotherapy",
"or",
"other",
"investigational",
"therapy",
"to",
"include",
"hormonal",
",",
"biological",
",",
"or",
"targeted",
"agents",
";",
"or",
"at",
"least",
"5",
"half-lives",
"from",
"hormonal",
",",
"biological",
",",
"or",
"targeted",
"agents",
",",
"whichever",
"is",
"shorter",
"at",
"the",
"time",
"of",
"treatment",
"initiation"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02346253
|
32:45:treatment
|
Prior allergic reaction to the study drug(s) involved in this protocol
| 1
|
[
"Prior",
"allergic",
"reaction",
"to",
"the",
"study",
"drug",
"(",
"s",
")",
"involved",
"in",
"this",
"protocol"
] |
[
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT01626079
|
70:91:chronic_disease
|
American College of Cardiology /American Heart Association (ACC/AHA) Stage D heart failure
| 1
|
[
"American",
"College",
"of",
"Cardiology",
"/American",
"Heart",
"Association",
"(",
"ACC/AHA",
")",
"Stage",
"D",
"heart",
"failure"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
2
] |
NCT01976585
|
7:17:cancer,
|
Prior malignancy (active within 5 years of screening)
| 1
|
[
"Prior",
"malignancy",
"(",
"active",
"within",
"5",
"years",
"of",
"screening",
")"
] |
[
0,
3,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02273362
|
34:38:treatment,181:195:treatment,207:245:chronic_disease,246:272:chronic_disease
|
individuals who use prescription PPIs and have approval from their primary health care provider to discontinue for the duration of clinical trial participation may be enrolled; an alternate drug to control gastroesophageal reflux disease (GERD)/peptic ulcer disease (PUD) symptoms will be suggested
| 1
|
[
"individuals",
"who",
"use",
"prescription",
"PPIs",
"and",
"have",
"approval",
"from",
"their",
"primary",
"health",
"care",
"provider",
"to",
"discontinue",
"for",
"the",
"duration",
"of",
"clinical",
"trial",
"participation",
"may",
"be",
"enrolled",
";",
"an",
"alternate",
"drug",
"to",
"control",
"gastroesophageal",
"reflux",
"disease",
"(",
"GERD",
")",
"/peptic",
"ulcer",
"disease",
"(",
"PUD",
")",
"symptoms",
"will",
"be",
"suggested"
] |
[
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
2,
2,
2,
2,
0,
0,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0
] |
NCT00632853
|
1:13:treatment
|
chemotherapy
| 1
|
[
"chemotherapy"
] |
[
1
] |
NCT02002260
|
12:20:treatment,24:36:treatment,70:74:treatment,78:85:treatment
|
History of ablation or hysterectomy or have any contraindications to COCs or LNG-IUS
| 1
|
[
"History",
"of",
"ablation",
"or",
"hysterectomy",
"or",
"have",
"any",
"contraindications",
"to",
"COCs",
"or",
"LNG-IUS"
] |
[
0,
0,
1,
0,
1,
0,
0,
0,
0,
0,
1,
0,
1
] |
NCT01676259
|
5:20:treatment,
|
All radiology scans must be performed within 28 days prior to registration
| 1
|
[
"All",
"radiology",
"scans",
"must",
"be",
"performed",
"within",
"28",
"days",
"prior",
"to",
"registration"
] |
[
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01620216
|
,100:109:treatment
|
Persons of reproductive potential must agree to use an adequate method of contraception throughout treatment
| 1
|
[
"Persons",
"of",
"reproductive",
"potential",
"must",
"agree",
"to",
"use",
"an",
"adequate",
"method",
"of",
"contraception",
"throughout",
"treatment"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02445768
|
1:12:chronic_disease,16:32:chronic_disease,48:51:treatment
|
subcortical or cortical infarct confirmed with MRI
| 1
|
[
"subcortical",
"or",
"cortical",
"infarct",
"confirmed",
"with",
"MRI"
] |
[
2,
0,
2,
2,
0,
0,
1
] |
NCT02434809
|
45:66:treatment
|
Deemed unable to safely undergo or tolerate flexible bronchoscopy as per institutional guidelines
| 1
|
[
"Deemed",
"unable",
"to",
"safely",
"undergo",
"or",
"tolerate",
"flexible",
"bronchoscopy",
"as",
"per",
"institutional",
"guidelines"
] |
[
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0
] |
NCT02414607
|
33:52:allergy_name
|
Known history of sensitivity to elderberry products
| 1
|
[
"Known",
"history",
"of",
"sensitivity",
"to",
"elderberry",
"products"
] |
[
0,
0,
0,
0,
0,
4,
4
] |
NCT02487095
|
1:4:chronic_disease,38:60:treatment,105:145:treatment,200:217:chronic_disease,236:262:treatment
|
HIV-positive subjects on combination antiretroviral therapy are ineligible because of the potential for pharmacokinetic interactions with VX-970. In addition, these subjects are at increased risk of lethal infections when treated with marrow-suppressive therapy
| 1
|
[
"HIV-positive",
"subjects",
"on",
"combination",
"antiretroviral",
"therapy",
"are",
"ineligible",
"because",
"of",
"the",
"potential",
"for",
"pharmacokinetic",
"interactions",
"with",
"VX-970",
".",
"In",
"addition",
",",
"these",
"subjects",
"are",
"at",
"increased",
"risk",
"of",
"lethal",
"infections",
"when",
"treated",
"with",
"marrow-suppressive",
"therapy"
] |
[
2,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
1,
1
] |
NCT02565498
|
9:21:treatment
|
Planned chemotherapy for (neo)adjuvant treatment
| 1
|
[
"Planned",
"chemotherapy",
"for",
"(",
"neo",
")",
"adjuvant",
"treatment"
] |
[
0,
1,
0,
0,
0,
0,
0,
0
] |
NCT02075710
|
10:13:chronic_disease
|
positive HIV antibody test or hepatitis serologies
| 1
|
[
"positive",
"HIV",
"antibody",
"test",
"or",
"hepatitis",
"serologies"
] |
[
0,
2,
0,
0,
0,
0,
0
] |
NCT02433977
|
88:101:chronic_disease,103:109:cancer,111:119:chronic_disease
|
Significant or uncontrolled concomitant medical illness including (but not limited to) heart disease, cancer, diabetes
| 1
|
[
"Significant",
"or",
"uncontrolled",
"concomitant",
"medical",
"illness",
"including",
"(",
"but",
"not",
"limited",
"to",
")",
"heart",
"disease",
",",
"cancer",
",",
"diabetes"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
3,
0,
2
] |
NCT03073629
|
,87:101:chronic_disease
|
comprehensive echocardiogram within 3 months of index hospital visit showing isolated RV dysfunction
| 1
|
[
"comprehensive",
"echocardiogram",
"within",
"3",
"months",
"of",
"index",
"hospital",
"visit",
"showing",
"isolated",
"RV",
"dysfunction"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2
] |
NCT02401347
|
54:68:cancer,,102:120:treatment,155:171:cancer
|
A repeated CT or MRI following the identification of CNS metastases (obtained at least 2 weeks after definitive therapy) must document adequately treated brain metastases
| 1
|
[
"A",
"repeated",
"CT",
"or",
"MRI",
"following",
"the",
"identification",
"of",
"CNS",
"metastases",
"(",
"obtained",
"at",
"least",
"2",
"weeks",
"after",
"definitive",
"therapy",
")",
"must",
"document",
"adequately",
"treated",
"brain",
"metastases"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
3,
3
] |
NCT02132130
|
,93:136:treatment
|
Patients with intact vestibular function in at least one ear (non-study ear) as measured by vestibular evoked myogenic potential (VEMP)
| 1
|
[
"Patients",
"with",
"intact",
"vestibular",
"function",
"in",
"at",
"least",
"one",
"ear",
"(",
"non-study",
"ear",
")",
"as",
"measured",
"by",
"vestibular",
"evoked",
"myogenic",
"potential",
"(",
"VEMP",
")"
] |
[
0,
0,
0,
1,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02562040
|
24:26:chronic_disease
|
Primary indication for AT is nocturnal obstructive symptoms (i.e., not recurrent infections or other indications)
| 1
|
[
"Primary",
"indication",
"for",
"AT",
"is",
"nocturnal",
"obstructive",
"symptoms",
"(",
"i.e.",
",",
"not",
"recurrent",
"infections",
"or",
"other",
"indications",
")"
] |
[
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03060772
|
14:36:treatment
|
Currently on pioglitazone treatment for another reason
| 1
|
[
"Currently",
"on",
"pioglitazone",
"treatment",
"for",
"another",
"reason"
] |
[
0,
0,
1,
1,
0,
0,
0
] |
NCT02442102
|
10:37:treatment
|
Expected tracheostomy tube placement while in hospital
| 1
|
[
"Expected",
"tracheostomy",
"tube",
"placement",
"while",
"in",
"hospital"
] |
[
0,
1,
1,
1,
0,
0,
0
] |
NCT03153410
|
33:45:treatment,
|
Must have received last dose of chemotherapy at least 14 days or longer prior to entry into the study
| 1
|
[
"Must",
"have",
"received",
"last",
"dose",
"of",
"chemotherapy",
"at",
"least",
"14",
"days",
"or",
"longer",
"prior",
"to",
"entry",
"into",
"the",
"study"
] |
[
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02533674
|
24:39:chronic_disease,41:62:chronic_disease,64:88:chronic_disease,93:138:chronic_disease,
|
History or presence of unstable angina, myocardial infarction, congestive heart failure, or clinically significant valvular heart disease within last year
| 1
|
[
"History",
"or",
"presence",
"of",
"unstable",
"angina",
",",
"myocardial",
"infarction",
",",
"congestive",
"heart",
"failure",
",",
"or",
"clinically",
"significant",
"valvular",
"heart",
"disease",
"within",
"last",
"year"
] |
[
0,
0,
0,
0,
2,
2,
0,
2,
2,
0,
2,
2,
2,
0,
0,
2,
2,
2,
2,
2,
0,
0,
0
] |
NCT00904046
|
21:33:treatment
|
Contraindication to pioglitazone use
| 1
|
[
"Contraindication",
"to",
"pioglitazone",
"use"
] |
[
0,
0,
1,
0
] |
NCT02132598
|
,,,,191:200:treatment
|
The subject has prothrombin time (PT)/ International Normalized Ratio (INR) or partial thromboplastin time (PTT) test ≥ 1.3 x the laboratory ULN within 7 days before the first dose of study treatment
| 1
|
[
"The",
"subject",
"has",
"prothrombin",
"time",
"(",
"PT",
")",
"/",
"International",
"Normalized",
"Ratio",
"(",
"INR",
")",
"or",
"partial",
"thromboplastin",
"time",
"(",
"PTT",
")",
"test",
"≥",
"1.3",
"x",
"the",
"laboratory",
"ULN",
"within",
"7",
"days",
"before",
"the",
"first",
"dose",
"of",
"study",
"treatment"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT00819208
|
63:75:treatment
|
patients who are pre-planned to receive a shorter duration of chemotherapy, including as part of a research study
| 1
|
[
"patients",
"who",
"are",
"pre-planned",
"to",
"receive",
"a",
"shorter",
"duration",
"of",
"chemotherapy",
",",
"including",
"as",
"part",
"of",
"a",
"research",
"study"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01871766
|
1:17:chronic_disease,
|
Serum creatinine based on age and gender
| 1
|
[
"Serum",
"creatinine",
"based",
"on",
"age",
"and",
"gender"
] |
[
2,
2,
0,
0,
0,
0,
0
] |
NCT02585973
|
41:51:cancer
|
Patients with a currently active second malignancy
| 1
|
[
"Patients",
"with",
"a",
"currently",
"active",
"second",
"malignancy"
] |
[
0,
0,
0,
0,
0,
0,
3
] |
NCT02304458
|
51:61:cancer
|
Patients must have had histologic verification of malignancy at original diagnosis or relapse
| 1
|
[
"Patients",
"must",
"have",
"had",
"histologic",
"verification",
"of",
"malignancy",
"at",
"original",
"diagnosis",
"or",
"relapse"
] |
[
0,
0,
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0
] |
NCT02931110
|
41:46:cancer,48:50:cancer,52:55:cancer,57:59:cancer,61:64:cancer,65:68:cancer,70:73:cancer,75:77:cancer,82:85:cancer
|
Part 2 (Cohort Expansion): Diagnosis of DLBCL, FL, MCL, HL, CLL/SLL, ALL, MM, or AML as documented in medical records
| 1
|
[
"Part",
"2",
"(",
"Cohort",
"Expansion",
")",
":",
"Diagnosis",
"of",
"DLBCL",
",",
"FL",
",",
"MCL",
",",
"HL",
",",
"CLL/SLL",
",",
"ALL",
",",
"MM",
",",
"or",
"AML",
"as",
"documented",
"in",
"medical",
"records"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
0,
3,
0,
3,
0,
3,
0,
3,
0,
3,
0,
3,
0,
0,
3,
0,
0,
0,
0,
0
] |
NCT01945814
|
21:44:chronic_disease
|
Patients with other uncontrolled infections (see 2.3.2 for definitions)
| 1
|
[
"Patients",
"with",
"other",
"uncontrolled",
"infections",
"(",
"see",
"2.3.2",
"for",
"definitions",
")"
] |
[
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0
] |
NCT02120222
|
22:61:cancer
|
Patients with active central nervous system (CNS) malignancy
| 1
|
[
"Patients",
"with",
"active",
"central",
"nervous",
"system",
"(",
"CNS",
")",
"malignancy"
] |
[
0,
0,
0,
3,
3,
3,
3,
3,
0,
0
] |
NCT02901314
|
27:29:chronic_disease,31:43:chronic_disease,47:82:chronic_disease,84:108:chronic_disease,112:136:chronic_disease
|
A non-traditional form of HF (hypertrophic or restrictive forms of cardiomyopathy, congenital heart disease or Takotsubo cardiomyopathy)
| 1
|
[
"A",
"non-traditional",
"form",
"of",
"HF",
"(",
"hypertrophic",
"or",
"restrictive",
"forms",
"of",
"cardiomyopathy",
",",
"congenital",
"heart",
"disease",
"or",
"Takotsubo",
"cardiomyopathy",
")"
] |
[
0,
0,
0,
0,
2,
0,
2,
0,
2,
2,
2,
2,
0,
2,
2,
2,
0,
2,
2,
0
] |
NCT02763228
|
,90:105:treatment,107:119:treatment,123:140:treatment,172:188:treatment,193:209:treatment
|
Patients who have completed treatment but are within five years of treatment completion (primary surgery, chemotherapy or radiation therapy), whichever was received last. Hormonal therapy and targeted therapy are allowed
| 1
|
[
"Patients",
"who",
"have",
"completed",
"treatment",
"but",
"are",
"within",
"five",
"years",
"of",
"treatment",
"completion",
"(",
"primary",
"surgery",
",",
"chemotherapy",
"or",
"radiation",
"therapy",
")",
",",
"whichever",
"was",
"received",
"last",
".",
"Hormonal",
"therapy",
"and",
"targeted",
"therapy",
"are",
"allowed"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
1,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
1,
1,
0,
0
] |
NCT01312857
|
23:38:treatment,39:55:treatment,102:111:treatment
|
Patients who have had prior anti EGFR antibody therapy inhibitors and who have not responded to this treatment will be excluded
| 1
|
[
"Patients",
"who",
"have",
"had",
"prior",
"anti",
"EGFR",
"antibody",
"therapy",
"inhibitors",
"and",
"who",
"have",
"not",
"responded",
"to",
"this",
"treatment",
"will",
"be",
"excluded"
] |
[
0,
0,
0,
0,
1,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0
] |
NCT02536846
|
22:40:chronic_disease
|
Without history of a psychotic disorder among parents, siblings, or children
| 1
|
[
"Without",
"history",
"of",
"a",
"psychotic",
"disorder",
"among",
"parents",
",",
"siblings",
",",
"or",
"children"
] |
[
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT02355912
|
1:7:chronic_disease
|
stroke
| 2
|
[
"stroke"
] |
[
2
] |
NCT00801489
|
20:43:treatment,26:43:treatment,222:244:treatment
|
Up to one cycle of prior induction therapy will be permitted to include patients in whom presence of good-risk cytogenetics was initially missed; if the patient is in remission from induction therapy, he/she will receive post-remission therapy; if the patient is not in remission then he/she will receive induction therapy
| 2
|
[
"Up",
"to",
"one",
"cycle",
"of",
"prior",
"induction",
"therapy",
"will",
"be",
"permitted",
"to",
"include",
"patients",
"in",
"whom",
"presence",
"of",
"good-risk",
"cytogenetics",
"was",
"initially",
"missed",
";",
"if",
"the",
"patient",
"is",
"in",
"remission",
"from",
"induction",
"therapy",
",",
"he/she",
"will",
"receive",
"post-remission",
"therapy",
";",
"if",
"the",
"patient",
"is",
"not",
"in",
"remission",
"then",
"he/she",
"will",
"receive",
"induction",
"therapy"
] |
[
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02560623
|
33:53:treatment
|
Undergoing clinically indicated diagnostic endoscopy
| 2
|
[
"Undergoing",
"clinically",
"indicated",
"diagnostic",
"endoscopy"
] |
[
0,
0,
0,
1,
1
] |
NCT02719327
|
1:9:chronic_disease
|
Dementia
| 2
|
[
"Dementia"
] |
[
2
] |
NCT02421380
|
15:28:chronic_disease
|
patients with brain lesions
| 2
|
[
"patients",
"with",
"brain",
"lesions"
] |
[
0,
0,
2,
2
] |
NCT02347891
|
15:39:treatment
|
Have received treatment with Belimumab at any time prior to Screening
| 2
|
[
"Have",
"received",
"treatment",
"with",
"Belimumab",
"at",
"any",
"time",
"prior",
"to",
"Screening"
] |
[
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0
] |
NCT02174549
|
1:22:treatment,31:49:treatment,51:74:treatment,79:96:treatment,120:125:cancer,146:161:treatment,204:207:treatment,213:226:treatment,
|
Prior local therapies such as surgical resection, radiofrequency ablation, or alcohol injection are allowed as long as tumor progresses from the prior treatment and the patients are still candidates for TAE. All prior therapy must be at least 4 weeks prior to enrollment and free from treatment-related toxicity
| 2
|
[
"Prior",
"local",
"therapies",
"such",
"as",
"surgical",
"resection",
",",
"radiofrequency",
"ablation",
",",
"or",
"alcohol",
"injection",
"are",
"allowed",
"as",
"long",
"as",
"tumor",
"progresses",
"from",
"the",
"prior",
"treatment",
"and",
"the",
"patients",
"are",
"still",
"candidates",
"for",
"TAE",
".",
"All",
"prior",
"therapy",
"must",
"be",
"at",
"least",
"4",
"weeks",
"prior",
"to",
"enrollment",
"and",
"free",
"from",
"treatment-related",
"toxicity"
] |
[
1,
1,
1,
0,
0,
1,
1,
0,
1,
1,
0,
0,
1,
1,
0,
0,
0,
0,
0,
3,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02562755
|
12:25:chronic_disease
|
History of severe eczema (as determined by the Investigator) requiring medical treatment
| 2
|
[
"History",
"of",
"severe",
"eczema",
"(",
"as",
"determined",
"by",
"the",
"Investigator",
")",
"requiring",
"medical",
"treatment"
] |
[
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01373099
|
49:70:treatment
|
Infection of a revision as opposed to a primary total hip arthroplast
| 2
|
[
"Infection",
"of",
"a",
"revision",
"as",
"opposed",
"to",
"a",
"primary",
"total",
"hip",
"arthroplast"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1
] |
NCT02465541
|
10:35:cancer
|
No prior type I endometrial cancer diagnosis
| 2
|
[
"No",
"prior",
"type",
"I",
"endometrial",
"cancer",
"diagnosis"
] |
[
0,
0,
3,
3,
3,
3,
0
] |
NCT00716066
|
1:30:chronic_disease
|
Active uncontrolled infection
| 2
|
[
"Active",
"uncontrolled",
"infection"
] |
[
2,
2,
2
] |
NCT02466750
|
18:31:chronic_disease
|
Have a confirmed HIV infection (antibody positivity)
| 2
|
[
"Have",
"a",
"confirmed",
"HIV",
"infection",
"(",
"antibody",
"positivity",
")"
] |
[
0,
0,
0,
2,
2,
0,
0,
0,
0
] |
NCT02578641
|
18:29:chronic_disease
|
Known history of hepatitis C
| 2
|
[
"Known",
"history",
"of",
"hepatitis",
"C"
] |
[
0,
0,
0,
2,
2
] |
NCT02771626
|
25:43:treatment,56:71:treatment,,87:97:treatment,119:157:treatment,
|
Any condition requiring systemic treatment with either corticosteroids (> 10 mg daily prednisone equivalent) or other systemic immunosuppressive medications within 2 weeks
| 2
|
[
"Any",
"condition",
"requiring",
"systemic",
"treatment",
"with",
"either",
"corticosteroids",
"(",
">",
"10",
"mg",
"daily",
"prednisone",
"equivalent",
")",
"or",
"other",
"systemic",
"immunosuppressive",
"medications",
"within",
"2",
"weeks"
] |
[
0,
0,
0,
1,
1,
1,
0,
1,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02264678
|
22:45:treatment
|
Contra-indicated for treatment with olaparib
| 2
|
[
"Contra-indicated",
"for",
"treatment",
"with",
"olaparib"
] |
[
0,
0,
1,
1,
1
] |
NCT01245712
|
1:31:cancer,107:116:treatment,120:137:treatment,146:154:treatment
|
Suspicious microcalcifications, or densities (in the ipsilateral or contralateral breast as documented on mammogram or breast ultrasound) unless biopsied and found to be benign
| 2
|
[
"Suspicious",
"microcalcifications",
",",
"or",
"densities",
"(",
"in",
"the",
"ipsilateral",
"or",
"contralateral",
"breast",
"as",
"documented",
"on",
"mammogram",
"or",
"breast",
"ultrasound",
")",
"unless",
"biopsied",
"and",
"found",
"to",
"be",
"benign"
] |
[
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
1,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0
] |
NCT02089607
|
46:66:chronic_disease
|
Presence of concomitant thoracoabdominal and aortic arch aneurysm meeting one of the above-mentioned criteria
| 2
|
[
"Presence",
"of",
"concomitant",
"thoracoabdominal",
"and",
"aortic",
"arch",
"aneurysm",
"meeting",
"one",
"of",
"the",
"above-mentioned",
"criteria"
] |
[
0,
0,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0
] |
NCT02389517
|
84:87:cancer
|
available deoxyribonucleic acid (DNA) sample will be used for calibration step for MRD evaluation by gene sequencing
| 2
|
[
"available",
"deoxyribonucleic",
"acid",
"(",
"DNA",
")",
"sample",
"will",
"be",
"used",
"for",
"calibration",
"step",
"for",
"MRD",
"evaluation",
"by",
"gene",
"sequencing"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
0,
0,
0,
0
] |
NCT01676259
|
1:18:chronic_disease
|
hepatitis C virus
| 2
|
[
"hepatitis",
"C",
"virus"
] |
[
2,
2,
2
] |
NCT02857218
|
45:72:cancer
|
Pathologically confirmed, locally advanced, malignancy of the esophagus
| 2
|
[
"Pathologically",
"confirmed",
",",
"locally",
"advanced",
",",
"malignancy",
"of",
"the",
"esophagus"
] |
[
0,
0,
0,
0,
0,
0,
3,
3,
3,
3
] |
NCT02177695
|
1:22:chronic_disease,
|
Peripheral neuropathy >/= Grade 2
| 2
|
[
"Peripheral",
"neuropathy",
">",
"/=",
"Grade",
"2"
] |
[
2,
2,
0,
0,
0,
0
] |
NCT02143830
|
1:31:cancer
|
Myelodysplastic Syndrome (MDS)
| 2
|
[
"Myelodysplastic",
"Syndrome",
"(",
"MDS",
")"
] |
[
3,
3,
3,
0,
0
] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.